Search Results - "Hernandez-Rocha C"

IL-6 is one of the key factors in the formation of gut tissue resident memory T cells from Naïve T cells.

Authors: Kim, Han G. Chan, Amanda Vimopatranon, Sinmanus et al.

Source: PLoS Pathogens. 3/16/2026, Vol. 22 Issue 3, p1-16. 16p.

Upadacitinib's Effectiveness and Safety as a Second- or Third-Line Therapy in Patients with Ulcerative Colitis: Data from a Real-World Study.

Authors: Mocci, Giammarco Tursi, Antonio Scaldaferri, Franco et al.

Source: Journal of Clinical Medicine. Nov2025, Vol. 14 Issue 21, p7801. 19p.

Definitions, diagnosis, management, and outcomes of upper gastrointestinal Crohn's disease: an international, expert RAND/UCLA appropriateness study.

Authors: Cohen NA Bettenworth D Sror N et al.

Corporate Authors: Cohen NA Bettenworth D Sror N et al.

Source: The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2026 Mar; Vol. 11 (3), pp. 243-255. Date of Electronic Publication: 2026 Jan 08.

Publication Type: Journal Article; Review

Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101690683 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2468-1253 (Electronic) NLM ISO Abbreviation: Lancet Gastroenterol Hepatol Subsets: MEDLINE

Identification of Pyrrolo [2,3- b ] Pyridine Derivatives as Novel JAK1 Inhibitors for the Treatment of Inflammatory Bowel Disease.

Authors: Wen, Shuai Xiao, Can Du, Li-Min et al.

Source: Molecules. Jul2026, Vol. 31 Issue 13, p2236. 23p.

Ulcerative colitis disease severity affects the speed of symptom relief under filgotinib treatment: a post hoc analysis of the phase 2b/3 SELECTION study.

Authors: Saruta, Masayuki Danese, Silvio Takatori, Yoshie et al.

Source: Intestinal Research. Apr2026, Vol. 24 Issue 2, p329-340. 12p.

CircRNA‐Centric ceRNA Network Profiling Reveals Potential Targets of Andrographolide in Murine Ulcerative Colitis.

Authors: Si, Caijuan Shu, Long Cao, Wenjing et al.

Source: Journal of Food Biochemistry. 7/7/2026, Vol. 2026, p1-15. 15p.

Subjects: Circular RNA, Competitive endogenous RNA, Inflammation, Gene expression, Immunoregulation, Ulcerative colitis, Laboratory mice, Andrographis paniculata

Upadacitinib induction therapy in Crohn' s disease: a retrospective real-world study in biologic-refractory patients.

Authors: Fu, Xiaoyu Tu, Lei Fu, Yu et al.

Source: BMC Gastroenterology. 10/8/2025, Vol. 25 Issue 1, p1-11. 11p.

Excessive activation of JAK-STAT signaling contributes to inflammation induced by acute Vibrio infection in shrimp.

Authors: Zuo, Hongliang Yang, Xiya Wang, Youxi et al.

Source: Virulence. Dec2025, Vol. 16 Issue 1, p1-14. 14p.

Drug tissue concentration and STAT3 modulation as determinants of tofacitinib response in ulcerative colitis.

Authors: Verstockt, Bram Alsoud, Dahham Oostrom, Joep van et al.

Source: Journal of Crohn's & Colitis. May2025, Vol. 19 Issue 5, p1-8. 8p.

Filgotinib to Treat Acute Severe Refractory Ulcerative Colitis: A Case Report and Review of the Literature.

Authors: Vespere, Giuliana Sedda, Silvia Madonna, Pasquale et al.

Source: Case Reports in Gastroenterology. 2025, Vol. 19 Issue 1, p289-297. 9p.

JAK–STAT inhibitory effect of IN‐115314, a novel small molecule inhibitor, and pharmacokinetic/pharmacodynamic study in canine.

Authors: Ahn, Jae‐Hun Kim, Joohwan Kwak, Jina et al.

Source: British Journal of Pharmacology. Oct2025, Vol. 182 Issue 20, p5071-5082. 12p.

Targeting JAK2 with a multifunctional nanoinhibitor for long-lasting anti-inflammatory effects and bone repair.

Authors: Liu, Yang Wang, Duan Zheng, Wenqian et al.

Source: Journal of Nanobiotechnology. 10/10/2025, Vol. 23 Issue 1, p1-21. 21p.

Emerging Therapies in Inflammatory Bowel Disease: A Comprehensive Review.

Authors: Appiah, John K. Hayat, Umar Garg, Nikita et al.

Source: Journal of Clinical Medicine. Sep2025, Vol. 14 Issue 17, p6119. 20p.

Continuous Treatment with Tofacitinib but Not Filgotinib Is Effective in Non-Responders with Active Ulcerative Colitis: A Propensity Score-Matching Analysis.

Authors: Yagi, Soichi Fukui, Hirokazu Ikenouchi, Maiko et al.

Source: Journal of Clinical Medicine. Jan2025, Vol. 14 Issue 1, p217. 11p.

Hit the road JAK: is there still hope left for TYK2 inhibition in IBD?.

Authors: Sharip, Mohmmed Tauseef Raine, Tim Noor, Nurulamin M

Source: Journal of Crohn's & Colitis. Jun2025, Vol. 19 Issue 6, p1-3. 3p.

Intestinal microbiota in adults with cholangiocarcinoma identifies the dysregulated Blautia species and bile acid metabolic pathways.

Authors: De, Tianyu Ma, Tian Wang, Wei et al.

Source: BMC Gastroenterology. 7/7/2025, Vol. 25 Issue 1, p1-13. 13p.

Prediction of Extraintestinal Manifestations in Inflammatory Bowel Disease Using Clinical and Genetic Variables with Machine Learning in a Latin IBD Group †.

Authors: Pérez-Jeldres, Tamara Reyes-Pérez, Paula Gonzalez-Hormazabal, Patricio et al.

Source: International Journal of Molecular Sciences. Jun2025, Vol. 26 Issue 12, p5741. 23p.

microRNA-34 mediates a negative feedback loop in the JAK-STAT pathway to attenuate immune overactivation in an invertebrate.

Authors: Zuo, Hongliang Liao, Alian Shen, Sihui et al.

Source: Cell Communication & Signaling. 5/17/2025, Vol. 23 Issue 1, p1-13. 13p.

Advancing therapeutic frontiers: a pipeline of novel drugs for UC management.

Authors: Bertin, Luisa Massano, Alessandro Redavid, Carlo et al.

Source: Frontiers in Gastroenterology (Frontiers Media S.A.). 2026, p1-31. 31p.

Amerindian ancestry proportion as a risk factor for inflammatory bowel diseases: results from a Latin American Andean cohort.

Authors: Pérez-Jeldres T Magne F Ascui G et al.

Source: Frontiers in medicine [Front Med (Lausanne)] 2023 Oct 27; Vol. 10, pp. 1258395. Date of Electronic Publication: 2023 Oct 27 (Print Publication: 2023).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE